Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MultiGeneAngio in Chronic Critical Limb Ischemia
NCT00956332Phase 2Active, not recruiting
- Sponsor
- MultiGene Vascular Systems
- Start
- Feb 2010
- Primary completion
- Aug 2011
- Modality
- Gene Editing, Gene Silencing, Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of MultiGeneAngio in critical limb ischemia (CLI), sponsored by MultiGene Vascular Systems. Started Feb 2010; status: active, not recruiting.
02
Drugs
MultiGeneAngio
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT00956332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00956332.